DUBLIN--(BUSINESS WIRE)--The "Global Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering. This report provides most ...
New York, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expected to Transform the Treatment ...
DUBLIN--(BUSINESS WIRE)--The "Focal Segmental Glomerulosclerosis (FSGS) - Market Insights, Epidemiology, and Market Forecast to 2028" drug pipelines has been added to ResearchAndMarkets.com's offering ...
Robert S. Katz, MD BOSTON—A widely used classification scheme for lupus glomerulonephritis (GN) may mask the pathologic and prognostic implications of focal segmental lupus GN, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback